Overview The PhilArt Eye skinbooster, developed by Croma laboratories, is a cutting-edge aesthetic solution dedicated to revitalizing the eye area. As part of the innovative PhilArt range, this injectable treatment aims to restore elasticity and firmness to the skin around the eyes. By promoting an optimal cellular environment, it helps reduce signs of fatigue and aging, providing a visibly younger and rested appearance.
Composition
& Rheology PN-HPT Technology (Highly Purified Polynucleotides) Polynucleotide concentration: 15 mg / 2 ml Crosslinking agent: OBT Volume: 2 ml pre-filled syringe
Indications
This device is highly recommended for treating the periorbital area. It targets the eye contour, eyelids, and superficial facial wrinkles. Its hydrating and redensifying action is perfect for smoothing crow's feet and firming the delicate tissues surrounding the eye. Dosage The administration of this product must be performed by a qualified practitioner.
Recommended injection techniques include microdroplets, linear threading, or the fan technique, using an appropriate needle. The precise protocol will depend on the patient's clinical assessment. Storage It is advisable to store this product in a dry place, away from direct sunlight and heat, at room temperature (typically between 2°C and 25°C). Do not freeze.
Contraindications Known allergy to components (polynucleotides) Presence of infection or inflammation in the treatment area Pregnant or breastfeeding women Patients with uncontrolled autoimmune diseases
FAQ
What is PN-HPT technology? It is a process for obtaining highly purified polynucleotides, known for their ability to retain water and stimulate skin tissue regeneration. How long do the effects last? Results vary depending on skin type and lifestyle, but hydration and skin texture improvements are generally long-lasting due to the biorevitalizing action.
Is the treatment painful? The injection is generally well tolerated. The use of a local anesthetic cream can be considered to maximize patient comfort.












